Table.
Indicators assessing the situation in terms of prevention of hepatitis B virus (HBV) infection at birth and in the first years of life, WHO South-East Asian Region
| Country | HBsAg prevalence estimates in children <5 yr of age (2019 working estimate)Ψ (%) | HBsAg prevalence estimates in the general population (2015)† (%) | HBV 3rd dose coverage (2019)‡ (%) | Timely birth dose coverage (2019)δ (%) | Antenatal care coverage (at least one visit, 2016-2018)§ (%) | Proportion of birth by skilled attendants (2016-2018)@ (%) | Verified by the WHO as having reached the 2020 one per cent target# | Programme for the prevention of mother-to-child transmission of HBV through testing in view of prophylaxis¥ |
|---|---|---|---|---|---|---|---|---|
| Indonesia | 4.2 | 2.43 | 85 | 84 | 97.5 | 94 | No | No |
| Myanmar | 2 | 4.18 | 90 | 17 | 80.7 | 60 | No | No |
| Timor Leste | 0.87ϕ | 2.00 | 83 | 70 | 84.4 | 57 | No | No |
| India | 0.51ϕ | 1.65 | 91 | 56 | 79.3 | 81 | No | No |
| The Democratic Republic of Korea | 0.5 | 4.40 | 97 | 98 | 99.5 | 100 | No | No |
| Nepal | 0.3 | 0.87 | 93 | N/A | 83.6 | 58 | Yes | No |
| Thailand | 0.2 | 1.36 | 97 | 99 | 98.1 | 99 | Yes | Yes |
| Maldives | 0.2 | 1.43 | 99 | 99 | 98.7 | 96 | No | No |
| Bangladesh | 0.05 | 4.00 | 98 | N/A | 81.9 | 53 | Yes | No |
| Sri Lanka | 0.01 | 2.04 | 99 | N/A | 98.8 | 100 | No | No |
| Bhutan | 0.3& | 4.29 | 97 | 86 | N/A | 96 | Yes | No |